Introduction
============

Miscarriage is the most common complication of pregnancy, defined as the spontaneous termination of pregnancy itself before the fetus has attained the stage of viability. Although only 15% of miscarriages are clinically recognized, total reproductive losses are closer to 50% of conceptions, and this complication is observed in about 1%--5% of couples trying to conceive,[@b1-ijwh-3-213] with a rising incidence.

Miscarriages can be sporadic or recurrent.[@b2-ijwh-3-213],[@b3-ijwh-3-213] Recurrent miscarriage, which traditionally corresponds to the termination of three or more consecutive pregnancies, has recently been defined in the guidelines of the American Society of Reproductive Medicine as the loss of two or more consecutive pregnancies.[@b4-ijwh-3-213] The etiology of recurrent miscarriage includes genetic abnormalities, autoimmune-related conditions, structural abnormalities, infections, and endocrine disorders, and is unknown in a significant number of miscarriages. Although chromosomal anomalies are identified in about 50%--60% of all miscarriages, they seem to occur less frequently in the products of conception (POC) from recurrent abortions than in those from sporadic abortions.[@b5-ijwh-3-213],[@b6-ijwh-3-213]

Because the gender ratio of live births in the human species is approximately 1.05, with males being slightly more represented, there might also be a gender rate distortion in spontaneous abortions, so that female POCs may be more susceptible to abortion than male ones.[@b7-ijwh-3-213] We investigated the karyotypes of abortuses in recurrent miscarriages, considering also gestational and maternal age at miscarriage, and evaluated the gender ratio of the miscarried POC and the incidence of chromosomal anomalies in the POC from recurrent miscarriage.

Materials and methods
=====================

We performed a retrospective analysis of recurrent miscarriages that occurred between January 1999 and June 2009 in patients admitted to the Department of Obstetrics and Gynecology at the University Hospital of Udine. We excluded material from first miscarriages, considering these more likely to be due to sporadic loss, as well as that from miscarriages at the end of gestational week 22 and from twin pregnancies.

We investigated the gender ratio of the POC, the incidence of miscarriage in relation to gestational age, frequency and type of chromosomal anomalies in abortuses, and incidence of chromosomal anomalies in male and female POC.

Chromosomal and cytogenetic analysis of recurrent miscarriages was carried out by the Department of Genetics at the University Hospital of Udine. Villi were isolated from POC specimens and cells were extracted to be cultured for karyotype analysis. Other specimen sources for karyotype analysis were the skin of miscarried POC and the placenta. We collected and examined all tissue samples after accurate removal of maternal blood and decidual tissue. Analysis of G-banded metaphase chromosomes was performed on cultured tissue samples using standard procedures. Karyotypes were described according to the 2005 guidelines of the International System for Human Cytogenetic Nomenclature.

Statistical analysis
--------------------

The statistical analysis was performed using R (version 2.10.1) and *P* \< 0.05 was considered to be statistically significant. The *t*-test, Chi-square test, and Fisher Exact test were used as appropriate.

Results
=======

A total of 313 POCs were included in the final analysis, miscarried at a median gestational age of 10 weeks (interquartile range \[IQR\] 8--13), by women of median age 35 years (IQR 31--39). Female POC were significantly more represented than male ones (64% versus 36%, *P* \< 0.05), even after stratification for gestational age ([Figure 1](#f1-ijwh-3-213){ref-type="fig"}), although statistical significance was reached only with regard to the whole population and gestational week 4--10 (*P* \< 0.001). The causes of miscarriage are reported separately in [Table 1](#t1-ijwh-3-213){ref-type="table"}, and the most frequent was idiopathic miscarriage.

Karyotype abnormalities explained miscarriage in 121 cases (39%), but could not account for miscarriage in 13 cases (4%). The most common anomalies were autosomal trisomies (84/134, 63%), which were more frequently observed in males than in females (38% versus 21%, *P* \< 0.05, [Figure 1](#f1-ijwh-3-213){ref-type="fig"}). The most frequent of them were trisomy 21 (n = 20) and trisomy 16 (n = 15). Trisomies 13, 15, 16, and 21 were more common in samples originating from males, whereas trisomies 2, 3, 4, 5, 18, 20, and 22 were more common among those with a female karyotype ([Figure 2](#f2-ijwh-3-213){ref-type="fig"}). Triploidy was the second most frequent abnormality in POC (21/134, 16%) of either gender. Monosomy and tetraploidy were found, respectively, in eight (6%) and four (3%) tissue samples, the latter being more prevalent in males than in females.

Discussion
==========

Our study found that in 313 karyotyped POC, 199 (64%) were females and 114 (36%) males, the difference being statistically significant (*P* \< 0.05) and suggesting a distorted gender ratio. Moreover, the most common anomalies were chromosome 21 and 16 trisomies, triploidy, and monosomy X, with trisomies having a higher incidence in males than in females.

The male to female ratio of births is known to be slightly in favor of males, and despite the lack of literature about gender ratio and miscarriages, these data are confirmed also in our population, where the male to female ratio was 1.06 ([Table 2](#t2-ijwh-3-213){ref-type="table"}). However, this ratio seems to have been lowering worldwide in favor of female births over the past few decades in Europe, the US, and Japan,[@b8-ijwh-3-213],[@b9-ijwh-3-213] probably due to increased prenatal vulnerability of male fetuses after gestational week 12.[@b10-ijwh-3-213],[@b11-ijwh-3-213] Also, in our population, of 72 intrauterine fetal deaths after gestational week 23, 58% were males and 42% were females (*P* \< 0.05), but these represented only a minority of adverse events (0.5% of deliveries). In fact, most of the miscarriages affect the first gestational trimester which is probably caused by karyotype anomalies. Furthermore, the presence of gender ratio distortion in miscarriages may be the cause of the higher prevalence of male newborns.[@b5-ijwh-3-213]

The median maternal age in our population was 35 years, which could account for the high prevalence of chromosomal abnormalities. To reduce contamination bias from maternal cells in this retrospective study, accurate selection of specimens for culture was performed by an experienced geneticist. Moreover, the risk of contamination was low for fetal skin and placenta samples at gestational weeks 11--22.

According to the current literature, autosomal trisomies are the most common karyotype anomaly, followed by triploidies in both genders,[@b12-ijwh-3-213] being significantly more frequent in male (50%, 57/114) than in female POC (32%, 64/199).[@b13-ijwh-3-213],[@b14-ijwh-3-213]

Despite the crucial role of chromosomal anomalies in recurrent miscarriages, their relatively low incidence (39%) suggests that other mechanisms may be responsible for recurrent miscarriages.[@b15-ijwh-3-213] According to evolutionary theory and the Dawkin's Selfish Gene theory, sexually antagonistic genes may be expressed during early genetic determination of gender.[@b16-ijwh-3-213],[@b17-ijwh-3-213] An example of sexual gene antagonism may be found in the butterfly, *Acrea encedon*, which has a gender imbalance of 97% favoring females as a result of sex chromosome drive.[@b16-ijwh-3-213]

In the 1980s, McGrath and Solter tried to create a uniparental mouse,[@b18-ijwh-3-213] finding the embryo from two mothers to be properly organized, but was not able to develop a functional placenta, and the embryo from two fathers was found to be disorganized despite the development of a large and healthy placenta. The presence of genetic sexual antagonism may explain the higher prevalence of female POC, because the imprinted male genes of the placenta are slightly more prone to favor a male embryo than a female one.

In our opinion, during the first trimester of pregnancy, miscarried female POC may be partially due to imprinted paternal genes. Further studies are required to confirm this theory, which is based on conflict in maintaining the equilibrium between genders in mammalian species and imprinting influences during intrauterine life.[@b19-ijwh-3-213]

Despite the retrospective nature of our study, and the limited clinical information it offers, the large number of cases strengthens our data. We conclude that female embryos are more prone to be miscarried than male ones in recurrent miscarriages, and that more research should be carried out to study the influence of imprinting on intrauterine life.

**Disclosure**

The authors report no conflicts of interest in this work.

![Male to female ratio in recurrent miscarriages (n = 313) by gestational age.](ijwh-3-213f1){#f1-ijwh-3-213}

![Trisomic distribution in male and female products of conception.](ijwh-3-213f2){#f2-ijwh-3-213}

###### 

Reasons for miscarriage in normal karyotypes and abnormal karyotypes identified in products of conception in 313 recurrent abortions

                                                                       **All population**   **Females**     **Males**      ***P***
  -------------------------------------------------------------------- -------------------- --------------- -------------- ---------
  Idiopathic miscarriage                                               49% (152/313)        57% (113/199)   34% (39/114)   \<0.05
    4--10 weeks                                                        44% (74/168)         55% (62/113)    22% (12/55)    \<0.05
    11--15 weeks                                                       42% (38/90)          49% (25/51)     33% (13/39)    0.135
    16--22 weeks                                                       72% (34/47)          71% (20/28)     74% (14/19)    0.865
  Other maternal pathologies                                           2% (6/313)           2% (4/199)      2% (2/114)     0.874
    4--10 weeks                                                        2% (3/168)           3% (3/113)      0% (0/55)      0.223
    11--15 weeks                                                       1% (1/90)            0% (0/51)       3% (1/39)      0.250
    16--22 weeks                                                       4% (2/47)            4% (1/28)       5% (1/19)      0.778
  Infection/cervical incontinence/PROM                                 2% (5/313)           1% (2/199)      3% (3/114)     0.269
    4--10 weeks                                                        NA                   NA              NA             
    11--15 weeks                                                       1% (1/90)            0% (0/51)       3% (1/39)      0.250
    16--22 weeks                                                       9% (4/47)            7% (2/28)       11% (2/19)     0.683
  Trisomies                                                            27% (84/313)         21% (41/199)    38% (43/114)   \<0.05
    4--10 weeks                                                        36% (60/168)         26% (29/113)    56% (31/55)    \<0.05
    11--15 weeks                                                       24% (22/90)          22% (11/51)     28% (11/39)    0.468
    16--22 weeks                                                       NA                   NA              NA             
  Monosomy X                                                           3% (8/313)           4% (7/199)      1% (1/114)     0.154
    4--10 weeks                                                        2% (3/168)           3% (3/113)      0% (0/55)      0.223
    11--15 weeks                                                       4% (4/90)            6% (3/51)       3% (1/39)      0.449
    16--22 weeks                                                       2% (1/47)            4% (1/28)       0% (0/19)      0.405
  Triploidy                                                            7% (21/313)          5% (9/199)      11% (12/114)   \<0.05
    4--10 weeks                                                        7% (12/168)          5% (6/113)      11% (6/55)     0.186
    11--15 weeks                                                       9% (8/90)            6% (3/51)       13% (5/39)     0.252
    16--22 weeks                                                       2% (1/47)            0% (0/28)       5% (1/19)      0.220
  Tetraploidy                                                          1% (4/313)           2% (3/199)      1% (1/114)     0.633
    4--10 weeks                                                        1% (2/168)           2% (2/113)      0% (0/55)      0.321
    11--15 weeks                                                       2% (2/90)            2% (1/51)       3% (1/39)      0.847
    16--22 weeks                                                       NA                   NA              NA             
  Separate rearrangements[\*](#tfn2-ijwh-3-213){ref-type="table-fn"}   5% (17/313)          5% (10/199)     6% (7/114)     0.675
    4--10 weeks                                                        7% (12/168)          6% (7/113)      9% (5/55)      0.494
    11--15 weeks                                                       2% (2/90)            2% (1/51)       3% (1/39)      0.847
    16--22 weeks                                                       6% (3/47)            7.14% (2/28)    5% (1/19)      0.796
  Fetal malformation                                                   5% (16/313)          5% (10/199)     5% (6/114)     0.927
    4--10 weeks                                                        1% (2/168)           1% (1/113)      2% (1/55)      0.601
    11--15 weeks                                                       13% (12/90)          14% (7/51)      13% (5/39)     0.900
    16--22 weeks                                                       4% (2/47)            7% (2/28)       0% (0/19)      0.234

**Notes:**

Separate rearrangements: 46, XX, −1, +der(1),t(1;18); 46, XX, −12, +der(12),t(11;12); 46, XX, der(4),t(4;8)mat; 46, XY, −5, +der(5),t(5:7); 46, XX, var(15p+),var(15p+) PCD.

**Abbreviations:** PROM, premature rupture of membranes; NA, not available.

###### 

Gender distribution of live births at our clinic between 2001 and 2008

  **Year**   **Female**       **Male**         ***P***
  ---------- ---------------- ---------------- ---------
  2001       47% (820/1730)   53% (910/1730)   0.423
  2002       50% (894/1804)   50% (910/1804)   0.254
  2003       46% (848/1833)   54% (985/1833)   0.061
  2004       49% (868/1773)   51% (905/1773)   0.556
  2005       49% (901/1840)   51% (939/1840)   0.541
  2006       49% (875/1793)   51% (918/1793)   0.651
  2007       49% (880/1796)   51% (916/1796)   0.528
  2008       47% (854/1799)   53% (945/1799)   0.451
